Drug Manufacturer Responds to Claims in Remicase Injury Case



DOCUMENTS
  • Answer
  • Complaint



EAST BRUNSWICK, N.J. - Claims asserted by a man who allegedly sustained injuries as a result of using Remicade are barred by the New Jersey Products Liability Act and preempted by the federal law, the manufacturer stated in response to the man's lawsuit. Randall E. Miller and Martha H. Miller v. Centocor, Inc., et al., MID-L-3099-03 (N.J. Sup. Ct., Middlesex Cty.).

Centocor, Inc., the company that makes the rheumatoid arthritis treatment, further argued in the July 3 answer that the case should be dismissed on forum non conveniens grounds because the plaintiff resides in Alabama and the suit was …






UPCOMING CONFERENCES




HarrisMartin's Webinar Series: Water Contamination Litigation Presented by EisnerAmper

May 06, 2025

MORE DETAILS



HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

April 08, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS